Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) ...

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...

Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

While the condition remains incurable, there are a ... Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...